Patients with T2D were characterized by elevated serum levels of G-CSF and IL-6 when compared to control (p < 0.0001 and p = 0.0002, respectively, Figure 3), whereas concentrations of IL-12 were decreased (p = 0.0008). This evidence concerns the gene IL6 and type 2 diabetes mellitus.